Logo
x

Search category

Subscribe Now

anemia

GSK Presents Results of Daprodustat in P-III ASCEND Program for the Treatment of Anemia due to Chronic Kidney Disease at ASN Kidney Week 2021

GSK Presents Results of Daprodustat in P-III ASCEND Program for the Treatment of Anemia due to Chronic Kidney Disease at ASN Kidne...

  • November 8, 2021
GSK Presents Results of Daprodustat in P-III ASCEND Program for the Treatment of Anemia due to Chronic Kidney Disease at ASN Kidney Week 2021

GSK Presents Results of Daprodustat in P-III ASCEND Program for the Treatment of Anemia due to Chronic Kidney Disease at ASN Kidne...

  • November 8, 2021
The US FDA's Rejects FibroGen's Roxadustat for the Treatment of Anemia Due to CKD

The US FDA's Rejects FibroGen's Roxadustat for the Treatment of Anemia Due to CKD

  • August 11, 2021
The US FDA's Rejects FibroGen's Roxadustat for the Treatment of Anemia Due to CKD

The US FDA's Rejects FibroGen's Roxadustat for the Treatment of Anemia Due to CKD

  • August 11, 2021
Akebia Presents Results of Vadadustat in P-lll INNO2VATE Program for Anemia Due to CKD at ASN Kidney Week

Akebia Presents Results of Vadadustat in P-lll INNO2VATE Program for Anemia Due to CKD at ASN Kidney Week

  • October 23, 2020
Akebia Presents Results of Vadadustat in P-lll INNO2VATE Program for Anemia Due to CKD at ASN Kidney Week

Akebia Presents Results of Vadadustat in P-lll INNO2VATE Program for Anemia Due to CKD at ASN Kidney Week

  • October 23, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.